Boehringer Ingelheim says it is on track to launch 25 new treatments in its human pharma division onto the market between now and 2030, fuelled by an R&D pipeline that it says is the best in its ...

Rgenta's in-house pipeline is headed by RGT-61159, a drug designed to inhibit the production of the cancer-associated MYB protein, which is in phase 1 testing. Also this week, GSK bolstered its ...

We’re nearly into June and the year is basically halfway over. Several gadget trade shows are already in the rearview, including High-End Munich, the Consumer Electronics Show (CES), Mobile World ...

The 1,700-mile (2,735-kilometer) pipeline was planned to carry roughly 800,000 barrels of oil a day from Alberta to the Texas Gulf Coast, passing through Montana, South Dakota, Nebraska ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.